Skip to content

Effect of Lemongrass aromatherapy on reducing anxiety

Evaluating the effect of Lemongrass aromatherapy on reducing the anxiety of patients undergoing scaling and root planing

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230615058492N2
Enrollment
40
Registered
2024-02-21
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Perceived pain during treatment. Anxiety disorder, unspecified Pain, unspecified

Interventions

Intervention 1: Intervention group: For this group, 3 drops (0.15 ml) of lemongrass essential oil (100% pure, non-edible) from Naringol brand (Tehran, Iran), which is originally a product of Moksha co

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 25 and 50 years Having periodontitis stage II to IV and grade A or B

Exclusion criteria

Exclusion criteria: History of scaling and root planing Having systemic conditions such as high blood pressure, diabetes or lung problems Smoking History of allergy to certain medicinal plants Having allergies or problems such as nasal congestion Loss of sense of smell due to Covid-19, etc Being diagnosed with sinusitis Being diagnosed with anxiety disorders The patient is pregnant The patient is breastfeeding The patient is receiving chemotherapy Taking pain relievers Taking anti-anxiety medications Taking medications that affect heart rate and blood pressure, such as diuretics and beta blockers Taking antiseizure medications Taking immunosuppressive medications

Design outcomes

Primary

MeasureTime frame
Anxiety score. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Spielberger’s State-Trait Anxiety Inventory–State Scale (containing 20 questions and scoring from 20 to 80).

Secondary

MeasureTime frame
Systolic blood pressure. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Digital sphygmomanometer model Ri-champion N from Riester® (measurement unit: millimeters Hg).;Diastolic blood pressure. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: Digital sphygmomanometer model Ri-champion N from Riester® (measurement unit: millimeters Hg).;Pulse rate. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: P-01 pulse oximeter device.;Arterial blood oxygen saturation percentage. Timepoint: Before the beginning of scaling and after scaling for two thirds of the teeth. Method of measurement: P-01 pulse oximeter device.;Pain grade on Visual Analogue Scale. Timepoint: After scaling for two thirds of the teeth. Method of measurement: Visual Analogue scale.;Patient satisfaction. Timepoint: After scaling for two thirds of the teeth. Method of measurement: Graded scale from 1 to 5 (1=dissatisfied/ 5=completely satisfied).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahta Sadat Vaezpour

Yazd University of Medical Sciences

vmahtasadat@gmail.com+98 35 3625 5881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026